查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1507987

2033年全球辅助生殖技术市场、机会与策略

Assisted Reproductive Technology Global Market Opportunities And Strategies To 2033
出版日期: | 出版商: The Business Research Company | 英文 393 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2018年全球辅助生殖技术（ART）市场价值为286.24亿美元，到2023年复合年增长率将超过5.0%。

多囊性卵巢症候群（PCOS）盛行率增加

PCOS（卵巢症候群）的高盛行率支持了绩效期间辅助生殖技术市场的成长。多囊性卵巢症候群是一种发生在育龄妇女身上的荷尔蒙失调。它是有卵巢的育龄人群中最常见的内分泌（荷尔蒙）疾病，保守估计影响 5-10% 的人口。 ART 为 PCOS 患者提供量身定制的治疗方案，解决与 PCOS 相关的特定生殖挑战，并增加成功怀孕和怀孕的机会。体外受精是一种更先进的 ART治疗方法，包括从卵巢中取出卵子，在实验室中用精子使卵子受精，然后将所得胚胎植入子宫。 PCOS 是女性不孕的主要原因之一，估计占「无排卵」（无排卵）不孕症病例的 80%。体外受精是提高多囊性卵巢症候群女性生育能力最常见的治疗方法之一。此外，根据瑞士专门机构世界卫生组织的数据，全球约有 1.16 亿女性 (3.4%) 受到多囊性卵巢症候群的影响。因此，PCOS病例的上升带动了历史时期辅助生殖技术市场的成长。

目录

第一章执行摘要

  • 辅助生殖技术 - 市场吸引力和宏观经济状况

第二章 目录

第三章表格一览

第四章图表一览

第五章 报告结构

第六章市场特点

  • 一般市场定义
  • 概述
  • 辅助生殖技术市场定义与细分
  • 市场区隔：按技术
    • 体外受精（IVF）
    • 人工授精（AI-IUI）
    • 其他技术
  • 市场区隔：按程序类型
    • 新鲜的非捐赠者
    • 新捐款者
    • 冷冻供体
    • 冷冻非捐赠者
    • 胚胎或卵子储存
  • 市场区隔：按最终用户
    • 医院
    • 不孕不育治疗诊所
    • 其他最终用户
  • 市场区隔诊断：通过测试
    • 排卵测试
    • 造影
    • 卵巢储备测试
    • 基因检测
    • 其他测试

第七章 主要市场趋势

  • 主要企业推出创新计划以推进 ART 并支持永续性
  • 人工智慧对辅助生殖技术的影响
  • 辅助生殖技术先进技术解决方案
  • 区块链在辅助生殖技术中的整合
  • 策略合作推动辅助生殖技术创新
  • 透过创新的不孕症治疗方案改善获得医疗保健的机会

第八章辅助生殖科技市场：宏观经济情景

  • COVID-19 的影响：辅助生殖技术市场
  • 乌克兰战争的影响：辅助生殖技术市场
  • 高通膨的影响：辅助生殖科技市场

第九章世界市场规模与成长

  • 市场规模
  • 2018-2023 年市场成长表现
    • 2018-2023年市场驱动因素
    • 2018-2023年市场限制因素
  • 2023-2028 年、2033 年市场成长预测
    • 2023-2028年市场驱动因素
    • 2023-2028年市场限制因素

第十章全球辅助生殖技术市场：细分

  • 全球辅助生殖科技市场：依科技分類的表现与预测，2018-2023、2028、2033
  • 全球辅助生殖技术市场：依手术类型分類的实际状况与预测，2018-2023、2028、2033
  • 全球辅助生殖技术市场：最终用户的表现和预测，2018-2023、2028、2033
  • 辅助生殖技术检测市场（ART检测/诊断）、表现及预测，2018-2023年、2028年、2033年
    • 全球其他测试市场：ART 测试/诊断的表现和预测，2018-2023、2028、2033

第十一章辅助生殖技术市场：区域与国家分析

  • 全球辅助生殖技术市场：按地区分類的表现与预测，2018-2023、2028、2033
  • 全球辅助生殖技术市场：依国家分類的表现与预测，2018-2023、2028、2033

第十二章亚太市场

第十三章西欧市场

第十四章 东欧市场

第十五章 北美市场

第十六章 南美洲市场

第十七章 中东市场

第十八章 非洲市场

第十九章 竞争格局及公司概况

  • Vitrolife AB
  • Ferring BV
  • Progyny Inc.
  • CooperSurgical Inc.
  • FUJIFILM Irvine Scientific, Inc.

第20章 竞争基准化分析

第 21 章竞争对手仪表板

第二十二章 重大併购

  • Hamilton Thorne Acquired Gynetics Medical Products
  • Reproductive Medicine Associates（RMA）And IVI-RMA Acquired Conceptions Reproductive Associates of Colorado
  • BPEA EQT Acquired Indira IVF
  • Calibre Scientific Acquired Microm UK Limited And Scopescreen
  • Liverpool Partners Acquired Genea Ltd.

第23章机会与策略

  • 2028年全球辅助生殖科技市场：提供新机会的国家
  • 2028年全球辅助生殖科技市场：提供新机会的细分市场
  • 2028 年全球辅助生殖技术市场：成长策略
    • 基于市场趋势的策略
    • 竞争策略

第24章辅助生殖技术市场：结论与建议

  • 结论
  • 推荐
    • 产品
    • 地方
    • 价格
    • 晋升
    • 人们

第25章附录

简介目录
Product Code: o&s1246

Assisted reproductive technology (ART) refers to fertility treatments and procedures that involve the manipulation of eggs, sperm or embryos to increase the likelihood of a successful pregnancy in humans. ART includes all fertility treatments in which either the eggs or the embryos are handled.

The assisted reproductive technology (ART) market consists of sales, by entities (organizations, sole traders and partnerships), of assisted reproductive technology (ART) procedures that are used for the treatment of infertility.

The global assisted reproductive technology (ART) market was valued at $28,624.0 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 5.0%.

Increasing Prevalence Of PCOS

The high prevalence of PCOS (polycystic ovary syndrome) condition supported the assisted reproductive technology market growth in the historic period. PCOS is a hormonal disorder that occurs in women of reproductive age. It is the most common endocrine (hormone) disorder in reproductive-age people with ovaries, affecting, conservatively, 5-10% of that population. ART offers tailored treatment options for individuals with PCOS, addressing the specific reproductive challenges associated with the condition and increasing the likelihood of successful conception and pregnancy. IVF is a more advanced ART procedure that involves the retrieval of eggs from the ovaries, fertilization with sperm in a laboratory setting, and transferring resulting embryos into the uterus. PCOS is one of the leading causes of female infertility, responsible for an estimated 80% of "anovulatory" (no ovulation) infertility cases. IVF is one of the most common treatments for women to increase fertility in women with PCOS. Furthermore, according to WHO, a Switzerland-based specialized agency, approximately 116 million women (3.4%) are affected by PCOS globally. Therefore, increased cases of PCOS drove the assisted reproductive technology market growth in the historic period.

Impact Of Artificial Intelligence On Assisted Reproductive Technology

Several key players operating in the assisted reproductive technology market are integrating efforts to introduce technological innovations, such as artificial intelligence (AI) software, to advance IVF treatment outcomes and lower the costs of the treatment. In IVF, AI algorithms analyze vast amounts of data from patient medical records, lab tests and imaging studies to identify patterns and make predictions. For instance, in October 2022, Alife, a US-based AI-based health technology firm, launched new artificial intelligence software to help fertility clinics optimize and support clinical decision-making during critical stages of the IVF process. Alife uses AI and significant U.S. IVF data sets to examine millions of patient cycle data points. The company's technology can help optimize the IVF treatment process from start to finish by reducing clinic operations and giving patients a more tailored experience.

The global assisted reproductive technology market is fairly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 17.9% of the total market in 2022.

Assisted Reproductive Technology Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global assisted reproductive technology market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for assisted reproductive technology? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The assisted reproductive technology market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider assisted reproductive technology market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by technology, by diagnosis/testing, by procedure type and by end-user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the assisted reproductive technology market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by technology, by diagnosis/testing, by procedure type and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for assisted reproductive technology providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Technology: In Vitro-Fertilization (IVF); Artificial Insemination (AI-IUI); Other Technologies
  • 2) By Procedure Type: Fresh Non-Donor; Fresh Donor; Frozen Donor; Frozen Non-Donor; Embryo or Egg Banking
  • 3) By End-User: Hospitals; Fertility Clinics; Other End-Users
  • 4) By Testing/Diagnosis: In Ovulation Testing; Hysterosalpingography; Ovarian Reserve Testing; Genetic Testing; Other Tests
  • Companies Mentioned: Vitrolife; Ferring B.V.; Progyny Inc.; CooperSurgical Inc.; FUJIFILM Irvine Scientific, Inc.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; assisted reproductive technology indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Assisted Reproductive Technology - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Assisted Reproductive Technology Market Definition And Segmentations
  • 6.4 Market Segmentation By Technology
    • 6.4.1 In Vitro-Fertilization (IVF)
    • 6.4.2 Artificial Insemination (AI-IUI)
    • 6.4.3 Other Technologies
  • 6.5 Market Segmentation By Procedure Type
    • 6.5.1 Fresh Non-Donor
    • 6.5.2 Fresh Donor
    • 6.5.3 Frozen Donor
    • 6.5.4 Frozen Non-Donor
    • 6.5.5 Embryo Or Egg Banking
  • 6.6 Market Segmentation By End-User
    • 6.6.1 Hospitals
    • 6.6.2 Fertility Clinics
    • 6.6.3 Other End-Users
  • 6.7 Market Segmentation By Diagnosis/Testing
    • 6.7.1 Ovulation Testing
    • 6.7.2 Hysterosalpingography
    • 6.7.3 Ovarian Reserve Testing
    • 6.7.4 Genetic Testing
    • 6.7.5 Other Test
      • 6.7.5.1 Computer Assisted Semen Analysis
      • 6.7.5.2 Sperm Penetration Assay
      • 6.7.5.3 Microscopic Examination
      • 6.7.5.4 Others Testing/Diagnosis

7 Major Market Trends

  • 7.1 Key Players Launching Innovative Programs To Promote ART and Support Sustainability
  • 7.2 Impact Of Artificial Intelligence On Assisted Reproductive Technology
  • 7.3 Advanced Technological Solutions In Assisted Reproductive Technology
  • 7.4 Blockchain Integration In Assisted Reproductive Technology
  • 7.5 Strategic Collaborations Driving Innovation In Assisted Reproductive Technology
  • 7.6 Innovative Fertility Treatment Options To Enhance Access To Care

8 Assisted Reproductive Technology Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On The Assisted Reproductive Technology Market
  • 8.2 Impact Of The War In Ukraine On The Assisted Reproductive Technology Market
  • 8.3 Impact Of High Inflation On The Assisted Reproductive Technology Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Assisted Reproductive Technology Market Segmentation

  • 10.1 Global Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.4 Global Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
    • 10.4.1 Global Other Tests Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Assisted Reproductive Technology Market, Regional and Country Analysis

  • 11.1 Global Assisted Reproductive Technology Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Assisted Reproductive Technology Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia-Pacific Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia-Pacific Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.6 Asia-Pacific Assisted Reproductive Technology Market: Country Analysis
  • 12.7 China Market
  • 12.8 Summary
    • 12.8.1 Market Overview
    • 12.8.2 Country Information
    • 12.8.3 Market Information
    • 12.8.4 Background Information
    • 12.8.5 Government Initiatives
    • 12.8.6 Regulations
    • 12.8.7 Regulatory Bodies
    • 12.8.8 Major Associations
    • 12.8.9 Taxes Levied
    • 12.8.10 Corporate Tax Structure
    • 12.8.11 Investments
    • 12.8.12 Major Companies
  • 12.9 China Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.10 China Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 China Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.12 China Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Market
  • 12.14 India Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 India Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.16 India Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 India Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.18 Japan Market
  • 12.19 Japan Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.20 Japan Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Japan Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.22 Japan Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Australia Market
  • 12.24 Australia Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Australia Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.26 Australia Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 Australia Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.28 Indonesia Market
  • 12.29 Indonesia Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.30 Indonesia Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.31 Indonesia Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.32 Indonesia Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.33 South Korea Market
  • 12.34 South Korea Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.35 South Korea Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.36 South Korea Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.37 South Korea Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate Tax Structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.2 Western Europe Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.6 Western Europe Assisted Reproductive Technology Market: Country Analysis
  • 13.7 UK Market
  • 13.8 UK Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 UK Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.11 UK Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany Market
  • 13.13 Germany Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 Germany Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.15 Germany Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 Germany Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Market
  • 13.18 France Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.19 France Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.20 France Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 France Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Italy Market
  • 13.23 Italy Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Italy Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Italy Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.26 Italy Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.27 Spain Market
  • 13.28 Spain Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.29 Spain Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.30 Spain Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.31 Spain Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Investments
    • 14.1.12 Major Companies
  • 14.2 Eastern Europe Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.6 Eastern Europe Assisted Reproductive Technology Market: Country Analysis
  • 14.7 Russia Market
  • 14.8 Russia Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.10 Russia Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.11 Russia Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.6 North America Assisted Reproductive Technology Market: Country Analysis
  • 15.7 USA Market
  • 15.8 Summary
    • 15.8.1 Market Overview
    • 15.8.2 Country Information
    • 15.8.3 Market Information
    • 15.8.4 Background Information
    • 15.8.5 Government Initiatives
    • 15.8.6 Regulations
    • 15.8.7 Regulatory Bodies
    • 15.8.8 Major Associations
    • 15.8.9 Taxes Levied
    • 15.8.10 Corporate Tax Structure
    • 15.8.11 Investments
    • 15.8.12 Major Companies
  • 15.9 USA Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.10 USA Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 USA Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.12 USA Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Market
  • 15.14 Canada Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.15 Canada Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.16 Canada Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.17 Canada Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Investments
    • 16.1.12 Major Companies
  • 16.2 South America Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.6 South America Assisted Reproductive Technology Market: Country Analysis
  • 16.7 Brazil Market
  • 16.8 Brazil Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.10 Brazil Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.11 Brazil Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Investments
    • 17.1.12 Major Companies
  • 17.2 Middle East Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.5 Middle East Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.1.1 Market Overview
    • 18.1.2 Region Information
    • 18.1.3 Market Information
    • 18.1.4 Background Information
    • 18.1.5 Government Initiatives
    • 18.1.6 Regulations
    • 18.1.7 Regulatory Bodies
    • 18.1.8 Major Associations
    • 18.1.9 Taxes Levied
    • 18.1.10 Corporate Tax Structure
    • 18.1.11 Investments
    • 18.1.12 Major Companies
  • 18.2 Africa Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.3 Africa Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.5 Africa Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Vitrolife AB
    • 19.1.1 Company Overview
    • 19.1.2 Products And Services
    • 19.1.3 Business Strategy
    • 19.1.4 Financial performance
  • 19.2 Ferring B.V.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial performance
  • 19.3 Progyny Inc.
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Performance
  • 19.4 CooperSurgical Inc.
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 FUJIFILM Irvine Scientific, Inc.
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Hamilton Thorne Acquired Gynetics Medical Products
  • 22.2 Reproductive Medicine Associates (RMA) And IVI-RMA Acquired Conceptions Reproductive Associates of Colorado
  • 22.3 BPEA EQT Acquired Indira IVF
  • 22.4 Calibre Scientific Acquired Microm UK Limited And Scopescreen
  • 22.5 Liverpool Partners Acquired Genea Ltd.

23 Opportunities And Strategies

  • 23.1 Global Assisted Reproductive Technology Market In 2028 - Countries Offering Most New Opportunities
  • 23.2 Global Assisted Reproductive Technology Market In 2028 - Segments Offering Most New Opportunities
  • 23.3 Global Assisted Reproductive Technology Market In 2028 - Growth Strategies
    • 23.3.1 Market Trend Based Strategies
    • 23.3.2 Competitor Strategies

24 Assisted Reproductive Technology Market, Conclusions And Recommendations

  • 24.1 Conclusions
  • 24.2 Recommendations
    • 24.2.1 Product
    • 24.2.2 Place
    • 24.2.3 Price
    • 24.2.4 Promotion
    • 24.2.5 People

25 Appendix

  • 25.1 Geographies Covered
  • 25.2 Market Data Sources
  • 25.3 Research Methodology
  • 25.4 Currencies
  • 25.5 The Business Research Company
  • 25.6 Copyright and Disclaimer